#sun pharma Tech News.
1 story in the last 7 days
The latest sun pharma news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks sun pharma across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
HealthET Tech36 minutes ago
Moody's, S&P boost Sun Pharma ratingsMoody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries for its proposed USD 11.75-billion acquisition of US-based Organon & Co. S&P gave a 'BBB+' rating, Moody's a 'Baa1', both with a 'stable' outlook.
Summaries by ByteBrief